Sanbo Brain Science: Revenue in 2025 was 1.725 billion yuan, with a year-on-year net profit decrease of 19.85%.

Sanbo Neurology announced that in 2025, the company achieved operating income of 1.725 billion yuan, a year-on-year increase of 20.69%; attributable net profit was 841.828 million yuan, a year-on-year decrease of 19.85%. The revenue growth was due to the increase in the scope of consolidated financial statements, as well as improved operational management and medical services. The decrease in profit was attributed to the fixed cost pressure brought about by the operation of new hospital branches. In addition, the company held 6 board meetings and 3 shareholder meetings throughout the year, with each professional committee fulfilling their duties well. In 2026, the company plans to improve governance, enhance disclosure, strengthen investor relations management, and utilize the capital market to drive development.